1 / 13

Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024

Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024; growing at a CAGR of 5.9% from 2016 to 2024. Diabetic nephropathy is a type of kidney disease commonly caused due to presence of diabetics. Presence of persistent proteinuria in a diabetic patient leads to diabetic nephropathy. Diabetic nephropathy comprises of 5 stages, with the final being end-stage renal disease (ESRD).

manojkumkar
Download Presentation

Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Diabetic Nephropathy Market Is Estimated To Reach $3,826 Million By 2024 ManojKumkar SEO Analyst help@variantmarketresearch.com sale@variantmarketresearch.com | help@variantmarketresearch.com

  2. DESCRIPTION- Diabetic Nephropathy Market Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024; growing at a CAGR of 5.9% from 2016 to 2024. Diabetic nephropathy is a type of kidney disease commonly caused due to presence of diabetics. Presence of persistent proteinuria in a diabetic patient leads to diabetic nephropathy. Diabetic nephropathy comprises of 5 stages, with the final being end-stage renal disease (ESRD). Advance stages of kidney diseases shows major symptoms of weakness, high blood pressure, vomiting, nausea, high albumin secretion in urine, leg swelling and high level of blood urea nitrogen. It can affect people with both type1 and type2 diabetes. Diabetic nephropathy affects around 40% of people suffering from type1 and type2 diabetics. It also increases the chances of cardiovascular mortality. Regular awareness programs are being initiated by various government and non-government organizations among diabetic population to inculcate the knowledge of preventive measures and treatments. Complete Browse Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market sale@variantmarketresearch.com | help@variantmarketresearch.com

  3. Diabetic Nephropathy Market Size and Forecast sale@variantmarketresearch.com | help@variantmarketresearch.com

  4. Diabetic Nephropathy Market The global diabetic nephropathy market is classified into mode of treatment and geography. Mode of treatment is bifurcated into drug modifying therapies (angiotensin-converting enzyme (ACE) inhibitor, angiotensin receptor blockers (ARBs), diuretics, calcium channel blockers (CCBs), renin inhibitors, connective tissue growth factor inhibitor (CTGF), antioxidant inflammation modulator (AIM), monocyte chemoattractant proteins (MCP) inhibitors, endothelin-A receptors antagonist (ETAR), G protein-coupled receptors (GPCRs) and others) and others. Get Sample Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market/sample-request sale@variantmarketresearch.com | help@variantmarketresearch.com

  5. Diabetic Nephropathy Market Share By Region sale@variantmarketresearch.com | help@variantmarketresearch.com

  6. Major Key Players • Bayer AG • Novartis AG • Eli Lilly and Company • Mallinckrodt Pharmaceuticals • Mitsubishi Tanabe Pharma Corporation • Mesoblast Ltd. • Ampio Pharmaceuticals Inc. • Reata Pharmaceuticals • GenKyoTex S.A. • ChemoCentryx Inc. sale@variantmarketresearch.com | help@variantmarketresearch.com

  7. The Key Takeaways From The Report • The report will provide a detailed analysis of Global Diabetic Nephropathy Market with respect to major segments such as mode of treatment and geography • The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024 • Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report • An exhaustive regional analysis of Global Diabetic Nephropathy Market from 2015 to 2024 will be included in the report • Profile of the key players in the Global Diabetic Nephropathy Market will be provided, which include key financials, product & services, new developments and business strategies sale@variantmarketresearch.com | help@variantmarketresearch.com

  8. Scope Of The Diabetic Nephropathy Market • Mode of Treatment Segments • Drug Modifying Therapies (DMT) • Angiotensin-Converting Enzyme (ACE) Inhibitor • Angiotensin Receptor Blockers (ARBs) • Diuretics • Calcium Channel Blockers (CCBs) • Renin Inhibitors • Connective Tissue Growth Factor Inhibitor (CTGF) • Antioxidant Inflammation Modulator (AIM) • Monocyte Chemoattractant Proteins (MCP) Inhibitors • Endothelin-A Receptors Antagonist (ETAR) • G Protein-Coupled Receptors (GPCRs) • Other Drug Modifying Therapies • Other Mode of Treatments sale@variantmarketresearch.com | help@variantmarketresearch.com

  9. Table Of Content Chapter 1 Prefix 1.1 Market Scope 1.2 Report Description 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In-house Data Modeling Chapter 2 Executive Summary sale@variantmarketresearch.com | help@variantmarketresearch.com

  10. Table Of Content Chapter 3 Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Value Chain Analysis 3.4 Market Dynamics 3.4.1 Drivers 3.4.1.1 Impact Analysis 3.4.2 Restraints 3.4.2.1 Impact Analysis 3.4.3 Opportunities 3.5 Porter’s five forces analysis 3.5.1 Factors Impact Analysis …………………….. sale@variantmarketresearch.com | help@variantmarketresearch.com

  11. Table Of Content Chapter 6 Company Profiles 6.1 Bayer AG 6.2 Novartis AG 6.3 Eli Lilly and Company 6.4 Mallinckrodt Pharmaceuticals 6.5 Mitsubishi Tanabe Pharma Corporation 6.6 Mesoblast Ltd. 6.7 Ampio Pharmaceuticals Inc. 6.8 Reata Pharmaceuticals 6.9 GenKyoTex S.A. 6.10 ChemoCentryx Inc. sale@variantmarketresearch.com | help@variantmarketresearch.com

  12. CONTACT US VARIANT MARKET RESEARCH LLP Website : https://www.Variantmarketresearch.Com Address: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com sale@variantmarketresearch.com | help@variantmarketresearch.com

  13. THANK YOU.. Sample request FOLLOW US Linked in Google Plus Twitter Facebook sale@variantmarketresearch.com | help@variantmarketresearch.com

More Related